[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR201710576A2 - A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM - Google Patents

A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM Download PDF

Info

Publication number
TR201710576A2
TR201710576A2 TR2017/10576A TR201710576A TR201710576A2 TR 201710576 A2 TR201710576 A2 TR 201710576A2 TR 2017/10576 A TR2017/10576 A TR 2017/10576A TR 201710576 A TR201710576 A TR 201710576A TR 201710576 A2 TR201710576 A2 TR 201710576A2
Authority
TR
Turkey
Prior art keywords
buffer
anal fissure
anal
microparticular
fissure treatment
Prior art date
Application number
TR2017/10576A
Other languages
Turkish (tr)
Inventor
Meri̇h Sariişik Ayşe
Yaprak Si̇nem
Rençber Seda
Önder Tolga
Ceylan Türkoğlu Gi̇zem
Original Assignee
Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dokuz Eyluel Ueniversitesi Rektoerluegue filed Critical Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority to TR2017/10576A priority Critical patent/TR201710576A2/en
Priority to PCT/TR2018/050377 priority patent/WO2019098958A2/en
Priority to EP18877697.5A priority patent/EP3654897A4/en
Publication of TR201710576A2 publication Critical patent/TR201710576A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
    • A61F13/2011—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use specially adapted for anal cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Buluş, anorektum bölgesi hastalığı anal fissürün medikal tedavisinde kullanılan hemostatik yara iyileştirici biyostabil ve biyobozunur tamponlar ile ilgilidir. Bu anal tamponlar, kalsiyum kanal blokeri ve lokal anestezik özellikli ilaç içermektedir.The invention relates to hemostatic wound healing biostable and biodegradable tampons used in the medical treatment of anorectum area disease anal fissure. These anal tampons contain calcium channel blocker and drug with local anesthetic properties.

TR2017/10576A 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM TR201710576A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM
PCT/TR2018/050377 WO2019098958A2 (en) 2017-07-19 2018-07-18 Tampon for anal fissure treatment which comprises a microparticulate system
EP18877697.5A EP3654897A4 (en) 2017-07-19 2018-07-18 Tampon for anal fissure treatment which comprises a microparticulate system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM

Publications (1)

Publication Number Publication Date
TR201710576A2 true TR201710576A2 (en) 2019-02-21

Family

ID=66540356

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/10576A TR201710576A2 (en) 2017-07-19 2017-07-19 A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM

Country Status (3)

Country Link
EP (1) EP3654897A4 (en)
TR (1) TR201710576A2 (en)
WO (1) WO2019098958A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0969813T3 (en) * 1997-02-24 2005-01-31 Sla Pharma Ag Topical pharmaceutical composition comprising a cholinergic or calcium channel blocking agent
BR9815499A (en) * 1997-07-02 2001-01-02 Euro Celtique Sa Prolonged anesthesia in joints and body spaces.
WO2004060447A2 (en) * 2002-12-31 2004-07-22 Ultra-Sonic Technologies, L.L.C. Transdermal delivery using encapsulated agent activated by ultrasound and/or heat
US9498431B2 (en) * 2008-12-10 2016-11-22 Jianjian Xu Controlled releasing composition
CA2901252A1 (en) * 2013-02-19 2014-08-28 David Jonathan HOCHMAN Therapeutic composition for the treatment perianal disorders

Also Published As

Publication number Publication date
EP3654897A4 (en) 2020-07-15
WO2019098958A3 (en) 2019-08-08
EP3654897A2 (en) 2020-05-27
WO2019098958A2 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
BR112015027699A2 (en) USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE
BR112016002821A2 (en) “ARTICLE FOR TREATMENT OF WOUNDS WITH SUPERABSORBENT FIBERS AND SUPERABSORBENT PARTICLES”
BR112016002781A2 (en) methods and devices for puncturing tissue
BR112015026006A2 (en) methods for treating cancer with the use of tor kinase inhibitor combination therapy
MX353942B (en) Post-procedure skin care systems, compositions, and methods of use thereof.
BR112018003822A2 (en) helper material to promote tissue growth in a colon
TR201901691T4 (en) Surgical procedure kit containing a device for suturing and surgical thread insertion.
EA201491009A1 (en) PLATINOUS LIZATE GEL
BR112012029293A2 (en) reinforced absorbable synthetic matrix for hemostatic applications
BR112015024234A2 (en) injectable sustained release composition and method for using it to treat joint inflammation and pain associated with it
AR108021A1 (en) ADJUSTMENTS OF ANTIBODY-ACTIVE PRINCIPLE (ADCS) OF KSP INHIBITORS WITH ANTI-B7H3 ANTIBODIES
IL242401B (en) Sanitary towels for women and urinary incontinence, gauze/bandages and surgical dressings for treating wounds, based on tourmaline
MX2017011806A (en) Mesh suture with anti-roping characteristics.
BR112022019094A2 (en) IN VIVO TISSUE MANIPULATION DEVICES, METHODS, AND REGENERATIVE AND CELLULAR MEDICINE USING ABSORBABLE MATERIAL DRAPES
CA2899775C (en) Compositions and methods for pain relief without numbness
IL290534A (en) Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods
TR201710576A2 (en) A BUFFER FOR ANAL FISSURE TREATMENT WITH A MICROPARTICULAR SYSTEM
SE1500342A1 (en) New bandage
BR112017028012A2 (en) THERAPY COMBINED WITH AN ANTIBODY-ANTI-HER2 DRUG CONJUGATE AND A BCL-2 INHIBITOR
ZA202000680B (en) Obinutuzumab treatment of a dlbcl patient subgroup
NZ771525A (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same
EA201990995A1 (en) AMSULIPRID POSTOPERATIVE VOMITAL THERAPY
NZ727147A (en) Combination therapy comprising olaratumab and doxorubicin
PH12014501044B1 (en) Methods for improved wound closure employing olivamine and human umbilical vien endothelial cells
MX2015009483A (en) Minimal invasion percutaneous repair clamps for the achilles tendon.